Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
[Antibiotics in routine practice. With proper selection rapid success]. 2002 MMW Fortschr Med pmid:12532526
Bogomil'skiÄ­ MP and Komarov RM [Azithromycin in the treatment of acute otitis media]. 2002 Antibiot. Khimioter. pmid:12515096
Hand WI and Hand DL [Mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes]. 2002 Antibiot. Khimioter. pmid:12516190
Di Paolo A et al. Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. 2002 Pharmacol. Res. pmid:12457629
Chiu LM et al. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers. 2002 J. Antimicrob. Chemother. pmid:12461037
Hauke W et al. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. 2002 Chemotherapy pmid:12476043
Kamau FN et al. Isocratic liquid chromatographic method for the analysis of azithromycin and its structurally related substances in bulk samples. 2002 J Chromatogr Sci pmid:12433117
Tyteca D et al. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. 2002 Exp. Cell Res. pmid:12441132
Aguirrebengoa K et al. [Endocarditis due to Bartonella henselae on a native valve. A new case with some notable aspects]. 2002 Enferm. Infecc. Microbiol. Clin. pmid:12372243
Ivashkin VT et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. 2002 World J. Gastroenterol. pmid:12378634
Wallace Jr RJ et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. 2002 J. Infect. Dis. pmid:12134265
Cheng H et al. Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent Gram-positive and Gram-negative antibacterial agents. 2002 Bioorg. Med. Chem. Lett. pmid:12161150
Kawashima M et al. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. 2002 Lung pmid:12182159
Yee CL et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. 2002 Pediatr. Infect. Dis. J. pmid:12182376
Clark C et al. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. 2002 Antimicrob. Agents Chemother. pmid:12183253
Blandizzi C et al. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. 2002 Antimicrob. Agents Chemother. pmid:11959610
Ekici A et al. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. 2002 J Asthma pmid:11990233
Mohler AM Treatment of streptococcal pharyngitis. 2002 Am Fam Physician pmid:11996411
Davis JL et al. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. 2002 J. Vet. Pharmacol. Ther. pmid:12000529
Ng LK et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. 2002 Antimicrob. Agents Chemother. pmid:12183262
Mandell GL and Coleman EJ Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. 2002 J. Infect. Dis. pmid:12001049
Prunier AL et al. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. 2002 Antimicrob. Agents Chemother. pmid:12183270
Treadway G et al. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections. 2002 Int. J. Antimicrob. Agents pmid:11932140
[Unfortunately without effectiveness: chlamydia eradication after infarct]. 2002 MMW Fortschr Med pmid:12014269
Suriawinata A and Min AD A 33-year-old woman with jaundice after azithromycin use. 2002 Semin. Liver Dis. pmid:12016551
Evans AT et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. 2002 Lancet pmid:12020525
King A et al. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. 2002 Clin. Microbiol. Infect. pmid:11952721
Nishikawa T [Comment on the contribution by Weigl CB et al. "Papillomatosis confluens et reticularis"]. 2002 Hautarzt pmid:12063751
Batieha A et al. No advantage of treating acute respiratory tract infections with azithromycin in a placebo-controlled study. 2002 Scand. J. Infect. Dis. pmid:12064684
Carryn S et al. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. 2002 Antimicrob. Agents Chemother. pmid:12069960
Babl FE et al. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. 2002 Antimicrob. Agents Chemother. pmid:12069974
Chimura T [Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. 2002 Jpn J Antibiot pmid:12071097
Reshetniak VI et al. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin]. 2002 Antibiot. Khimioter. pmid:12087718
Kays MB et al. Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. 2002 Diagn. Microbiol. Infect. Dis. pmid:12088625
Breier AR et al. Microbiological assay for azithromycin in pharmaceutical formulations. 2002 J Pharm Biomed Anal pmid:12093530
Muirhead GJ et al. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers. 2002 Br J Clin Pharmacol pmid:11879258
Gomberg MA [Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa]. 2002 Antibiot. Khimioter. pmid:12365322
Hammerschlag MR Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:12370232
Adimora AA Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. 2002 Clin. Infect. Dis. pmid:12353204
Augenbraun MH Treatment of syphilis 2001: nonpregnant adults. 2002 Clin. Infect. Dis. pmid:12353205
Itoh M et al. [A case of immotile-dyskinetic cilia syndrome responding to clenbuterol hydrochloride and azithromycin]. 2002 Nihon Kokyuki Gakkai Zasshi pmid:12382429
Equi A et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. 2002 Lancet pmid:12383667
Neumann FJ Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. 2002 Circulation pmid:12417534
Skerk V et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. 2002 J Chemother pmid:12420857
Sieper J and Braun J [Diagnosis and antibiotic treatment of reactive arthritis]. 2002 Dtsch. Med. Wochenschr. pmid:12226789
Chandrupatla S et al. Azithromycin-induced intrahepatic cholestasis. 2002 Dig. Dis. Sci. pmid:12395890
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Duff P Antibiotic selection in obstetrics: making cost-effective choices. 2002 Clin Obstet Gynecol pmid:11862059
Wolter J et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. 2002 Thorax pmid:11867823
Zhou F et al. High accuracy mass measurement of peptides with internal calibration using a dual electrospray ionization sprayer system for protein identification. 2002 Rapid Commun. Mass Spectrom. pmid:11870887
Krudsood S et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. 2002 Southeast Asian J. Trop. Med. Public Health pmid:12693587
Burton MJ et al. Azithromycin for the treatment and control of trachoma. 2002 Expert Opin Pharmacother pmid:11829725
Ohara T et al. [Protective effect of azithromycin against verotoxin]. 2002 Kansenshogaku Zasshi pmid:11905000
Salaria M and Singh M Atypical pneumonia in children. 2002 Indian Pediatr pmid:11910135
Desta Z et al. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin. 2002 J Clin Psychopharmacol pmid:11910261
Ito N and Kudo S [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM]. 2002 Jpn J Antibiot pmid:12664928
Smith SR et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. 2002 J. Clin. Periodontol. pmid:11846850
Wu ML et al. Enterocolonic Mycobacterium avium-intracellulare. 2002 Arch. Pathol. Lab. Med. pmid:11860323
Schachter J and Dawson CR Elimination of blinding trachoma. 2002 Curr. Opin. Infect. Dis. pmid:12686881
Kutlin A et al. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. 2002 Antimicrob. Agents Chemother. pmid:11796350
Strle F and Maraspin V Is azithromycin treatment associated with prolongation of the Q-Tc interval? 2002 Wien. Klin. Wochenschr. pmid:12708094
Dawson CR and Schachter J Should trachoma be treated with antibiotics? 2002 Lancet pmid:11812548
Zubata P et al. A new HPLC method for azithromycin quantitation. 2002 J Pharm Biomed Anal pmid:11814725
Lentino JR and Krasnicka B Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia. 2002 Int. J. Antimicrob. Agents pmid:11814769
Phillips P et al. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. 2002 Clin. Infect. Dis. pmid:11774085
Dai G et al. [Researching some sensitivity factor of bioassay method on the antibiotics pharmacokinetics]. 2002 Hunan Yi Ke Da Xue Xue Bao pmid:12575254
Dzelalija B et al. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. 2002 Acta Med Croatica pmid:12596623
Nalbanski B and Nalbanski A [Treatment of Chlamydia trachomatis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935692
Krumov G et al. [Treatment of chlamydial cervicitis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935693
Silva FM et al. Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. 2002 Jan-Feb Rev Hosp Clin Fac Med Sao Paulo pmid:12170343
Kadappu KK et al. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. 2002 Jul-Sep J Postgrad Med pmid:12432190
Yaqubi GH and Anani GR Prevalence of trachoma in chronic conjunctivitis, Birjand, Islamic Republic of Iran. 2002 Mar-May East. Mediterr. Health J. pmid:15339124
Basilion EV et al. Height as a proxy for weight in determining azithromycin treatment for paediatric trachoma. 2002 Nov-Dec Trans. R. Soc. Trop. Med. Hyg. pmid:12625152
Mileusnic D et al. Pathological case of the month: sudden death in a child as a result of pancreatitis during valproic acid therapy. 2002 Sep-Oct Pediatr Pathol Mol Med pmid:12396903
Debremaeker D et al. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry. 2003 Rapid Commun. Mass Spectrom. pmid:12569445
Mehta CL Arcanobacterium haemolyticum. 2003 J. Am. Acad. Dermatol. pmid:12582410
Nieuwenhuis RF et al. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. 2003 Sex Transm Infect pmid:14663119
Pichichero ME et al. Azithromycin for the treatment of pertussis. 2003 Pediatr. Infect. Dis. J. pmid:14515842
Nafar M et al. A comparison between the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingival overgrowth in kidney transplant patients. 2003 Transplant. Proc. pmid:14612094
Plouffe JF et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. 2003 Clin. Infect. Dis. pmid:14614670
Al-Belasy FA and Hairam AR The efficacy of azithromycin in the treatment of acute infraorbital space infection. 2003 J. Oral Maxillofac. Surg. pmid:12618970
Batt SL et al. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. 2003 Antimicrob. Agents Chemother. pmid:12936971
Henry DC et al. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. 2003 Antimicrob. Agents Chemother. pmid:12936972
Falk L et al. Tetracycline treatment does not eradicate Mycoplasma genitalium. 2003 Sex Transm Infect pmid:12902584
Nigović B and Simunić B Voltammetric assay of azithromycin in pharmaceutical dosage forms. 2003 J Pharm Biomed Anal pmid:12852463
Gologan R et al. Multiple myeloma in remission complicated by bone marrow granulomas. 2003 Rom J Intern Med pmid:15526516
Kogan R et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. 2003 Pediatr. Pulmonol. pmid:12526069
Derelle J [Anti-inflammatory therapy in cystic fibrosis]. 2003 Arch Pediatr pmid:14671937
Lederman HM et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. 2003 J. Infect. Dis. pmid:14673757
Salcedo Posadas A et al. [Complementary therapies in cystic fibrosis: evidence of therapeutic benefits and treatment recommendations]. 2003 An Pediatr (Barc) pmid:12628117
Amsden GW et al. Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis. 2003 Chest pmid:12628877
Kuvin JT et al. Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. 2003 Am. J. Cardiol. pmid:12633811
Jang D et al. Correlation between culture testing of swabs and ligase chain reaction of first void urine from patients recently treated for Chlamydia trachomatis. 2003 Sex Transm Infect pmid:12794211
Hunter RP et al. Azithromycin metabolite identification in plasma, bile, and tissues of the ball python (Python regius). 2003 J. Vet. Pharmacol. Ther. pmid:12667181
Gerhardt SG et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. 2003 Am. J. Respir. Crit. Care Med. pmid:12672648
Schilling F [SAPHO syndrome. A contribution to discussion]. 2003 Wien. Klin. Wochenschr. pmid:12674695
Hoffman HL et al. Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. 2003 Antimicrob. Agents Chemother. pmid:12543686
Javaloy J et al. Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population: molecular and clinical diagnosis. 2003 Br J Ophthalmol pmid:12543737
Gaynor BD et al. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. 2003 Br J Ophthalmol pmid:12543738
Niv Y and Abuksis G Survey of the opinions, knowledge and practices of surgeons and internists regarding Helicobacter pylori test-and-treat policy. 2003 J. Clin. Gastroenterol. pmid:12544197